Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy.

Yonsei Med J · 2017 · PMC5447099 · PMID 28540981

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Secondary outcomes The PiCM upgrade group showed the highest responder rates, although the clinical and echocardiographic responder rates at 6 month did not reach statistical significance ( Table 2 , Fig. 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.